Two post-mortem studies in schizophrenia both showed a significant increase (35 to 55%) in the A2A receptor (A2AR) in the basal ganglia of patients with this disorder when compared to healthy controls (Kurumaji and Toru 1998; Deckert et al. 2003). This evidence concerns the gene ADORA2A and schizophrenia.